Breast Cancer Core Needle Biopsy Market to grow with a CAGR of 8.90% through 2029

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Breast Cancer Core Needle Biopsy Market during the forecast period 2025-2029 

According to TechSci Research report, “Global Breast Cancer Core Needle Biopsy Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2029F”, Global Breast Cancer Core Needle Biopsy Market has valued at USD 0.80 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.90% through 2029. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

Technological advancements in imaging have significantly propelled the Global Breast Cancer Core Needle Biopsy Market by enhancing the accuracy, efficiency, and accessibility of core needle biopsies. Modern imaging modalities like digital mammography, tomosynthesis (3D mammography), ultrasound, and MRI offer higher resolution and clearer images of breast abnormalities, facilitating better detection of suspicious lesions. This heightened detection prompts the necessity for core needle biopsies to ascertain their nature accurately. Advanced imaging techniques enable radiologists and healthcare providers to visualize breast abnormalities with greater precision, aiding in the precise targeting of biopsy needles during procedures. Real-time guidance provided by imaging technologies during core needle biopsies ensures accurate needle placement, minimizing sampling errors and enhancing diagnostic accuracy. The integration of imaging modalities, such as combining MRI and ultrasound images, further augments the precision of lesion localization and biopsy guidance.

Personalized medicine, which involves tailoring treatments based on individual patient characteristics, is gaining prominence in breast cancer management. Core needle biopsy enables the analysis of specific biomarkers and genetic mutations, facilitating the selection of targeted therapies. The increasing focus on personalized medicine is driving the demand for core needle biopsy procedures.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Breast Cancer Core Needle Biopsy Market”

Image-guided biopsies, including ultrasound-guided and stereotactic-guided techniques, are becoming increasingly prominent due to their precise targeting of suspicious lesions. These methods offer real-time visualization, enabling physicians to accurately guide the needle to the intended site. The rising adoption of image-guided biopsies is projected to stimulate market growth.

In the field of oncology, personalized medicine, which involves customizing treatment plans based on individual patient characteristics, is gaining momentum. Core needle biopsy facilitates the analysis of specific biomarkers and genetic mutations, facilitating the selection of targeted therapies. The growing focus on personalized medicine is anticipated to drive demand for breast cancer core needle biopsy. 

Breast cancer core needle biopsy utilizes a hollow needle and specialized apparatus to extract tissue samples for precise evaluation, aiding in accurate cancer diagnosis. The market for this procedure is expanding due to rising breast cancer rates, widespread mammography recommendations, heightened awareness, and extensive research efforts. Breast cancer stands as the most prevalent cancer globally, with nearly 2.3 million cases, 685,000 fatalities, and 7.8 million survivors reported worldwide in 2020.

Competition and market saturation pose challenges for the Global Breast Cancer Core Needle Biopsy Market. As competition intensifies and market saturation looms, various factors come into play, affecting growth and profitability for industry participants. Increasing demand attracts more providers and companies, heightening competition and potentially triggering price wars and narrower profit margins. To sustain financial viability, companies must differentiate themselves through quality, innovation, service, and customer experience, ensuring unique value propositions. However, in a crowded market, showcasing distinct offerings becomes challenging, potentially leading to a convergence in products and services. Moreover, market saturation can prompt shifts in market share, with established players facing threats from new entrants or aggressive competitors. Amidst this landscape, maintaining market positions requires strategic adaptation and resilience to dynamic market forces.

Global Breast Cancer Core Needle Biopsy Market segmentation is based on Technology, End Use, and Region

Based on End Use, the Global Breast Cancer Core Needle Biopsy Market Hospitals & Diagnostic Laboratories segment held the largest share and is predicted to continue expanding over the coming years. Hospitals and diagnostic laboratories often serve as centralized locations for various medical tests and procedures. Breast cancer core needle biopsies are performed in these facilities due to the availability of specialized equipment, trained medical personnel, and a controlled environment for sterile procedures. Hospitals and diagnostic laboratories have the necessary infrastructure to conduct a wide range of medical tests and procedures. This includes access to advanced imaging technologies (such as ultrasound, MRI, and mammography) that are often used to guide the needle during the biopsy procedure. Many hospitals employ multidisciplinary teams of experts, including radiologists, pathologists, oncologists, and surgeons. Breast cancer diagnosis and treatment often involve collaboration between these specialists, making hospitals well-equipped to offer comprehensive care, including core needle biopsies.

The Asia Pacific region is poised to experience the most rapid growth in the Global Breast Cancer Core Needle Biopsy Market. This growth is fueled by a surge in breast cancer cases attributed to shifting lifestyles, aging demographics, and heightened awareness. The increased incidence underscores the necessity for precise diagnostic methods like core needle biopsies. Several countries in the Asia Pacific have been enhancing their healthcare infrastructure, including diagnostic facilities and medical equipment, making core needle biopsies more accessible to a wider populace. Concurrently, initiatives to boost breast cancer awareness and encourage regular screenings have gained momentum, promoting early detection and diagnostic procedures, thereby bolstering market expansion. Urbanization and lifestyle modifications in the region have contributed to factors linked to elevated breast cancer risk, such as sedentary habits, dietary shifts, and hormonal influences.

Some of the major companies operating in the Global Breast Cancer Core Needle Biopsy Market include:

• Intact Medical Corporation
• Ethicon Endo Surgery
• Galini SRL
• Leica Biosystems Nussloch GmbH
• Hologic Inc.
• Argon Medical Devices
• Encapsule Medical Devices LLC.
• Cook Medical Incorporated
• Becton & Dickinson Company
• C.R. Bard, Inc.

Download Sample Report

Customers can also request 10% free customization on this report

“Certain areas, particularly in North America, are projected to exert significant demand for breast cancer biopsy. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Breast Cancer Core Needle Biopsy Market in the forecast period", said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

"Breast Cancer Core Needle Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Technology (MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Other Image Based Breast Biopsy), By End Use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology companies, Academic & Research Institutes), and By Region, Competition, 2019-2029F" evaluated the future growth potential of Global Breast Cancer Core Needle Biopsy Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Breast Cancer Core Needle Biopsy Market.

Contact

TechSci Research LLC

420 Lexington Avenue,

Suite 300, New York,

United States- 10170

M: +13322586602

Email: [email protected]

Website: https://www.techsciresearch.com